Company news
Joincare Pharmaceutical Group Industry Co., Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Announcement on the Election of by the Employee Meeting
November 14, 2025
Indicative Announcement on Convening the 2nd Extraordinary General Meeting in 2025
November 7, 2025
Announcement on Resolutions of the 10th Meeting of the 9th Board of Supervisors
October 24, 2025
Announcement on Outline of the 2025 Semi-annual Performance Briefing
September 19, 2025
Announcement on Release of Pledge of Partial Equity of Shareholder
September 8, 2025
Announcement on Convening the 2025 Semi-annual Performance Briefing
August 22, 2025
Indicative Announcement on Acceptance of Applications for Drug Registration and Market Authorization
August 15, 2025
Announcement on Resolutions of the 11th Meeting of the 9th Board of Directors
July 25, 2025
Indicative Announcement on the Phase Ⅲ Clinical Trial of Recombinant Anti-Human IL-17A/F Humanized Monoclonal Antibody Injection Reaching the Primary Study Endpoint
July 21, 2025
Announcement on Implementation of Dividend Distribution for 2024
July 10, 2025
Announcement on Progress in Providing Entrusted Loans to Holding Subsidiary Jiaozuo Jianfeng
June 25, 2025
Announcement on Obtaining Notice of Approval for Clinical Trial
June 19, 2025
Announcement on Resolutions of the 2024 Annual General Meeting
June 6, 2025
Announcement on Progress in Providing Guarantee
June 5, 2025
Announcement on Obtaining Production License by Subsidiary in the Netherlands
May 29, 2025
Indicative Announcement on Convening the 2024 Annual General Meeting
May 27, 2025
Announcement on Holding Subsidiary Livzon Group Planning to Acquire Equity of Vietnam IMP Company
May 22, 2025
Announcement on Outline of the 2024 Annual and Q1 2025 Performance and Cash Dividend Briefing
May 12, 2025
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
May 9, 2025
Announcement on the Completion of Cancellation of Remaining Stock Options in 2022 Stock Option Incentive Plan
May 6, 2025
Indicative Announcement on Convening the 1st Extraordinary General Meeting in 2025
April 28, 2025